Weng Wanwen, Dong Mengjie, Zhang Jun, Yang Jun, Zhang Bo, Zhao Xingdong
Department of Nuclear Medicine, The First Affiliated Hospital, College of Medicine, Zhejiang University, Hangzhou, China.
Medicine (Baltimore). 2017 Jun;96(25):e7279. doi: 10.1097/MD.0000000000007279.
Low-iodine intake has historically been an issue in China, causing widespread iodine deficiency diseases (IDD). China started to introduce universal salt iodization in 1995, but reports of increased thyroid disease are a concern and appropriate levels of iodine intake must be considered.
To assess the prevalence of thyroid disease with different urinary iodine concentrations (UICs) in the general population of those residing in mainland China. Furthermore, we aimed to analyze the relationship between thyroid disease and UIC, to provide guidance in establishing effective health policies regarding iodine intake.
PubMed, Cochrane, Embase, CNKI, Wan fang, and CQVIP databases were searched for random community-based relevant studies with UIC published before January 2016 in mainland China. Two independent reviewers extracted data from eligible citations, and obtained prevalence of thyroid disease for different UICs, as well as the intergroup interaction P values.
Forty-three articles were included. The prevalence of thyroid nodules was 22.3% (95% confidence interval [CI]: 20.6%-24.1%) for the low-iodine group, 25.4% (95% CI: 20.8%-28.8%) for the medium-iodine group, and 6.8% (95% CI: 2.8%-11.5%) for the high-iodine group. In the high-iodine group, the prevalence of thyroid nodules was lower than the other groups. The prevalence of 8.3% (95% CI: 3.8%-17.3%) for subclinical hypothyroidism in the high-iodine group was significantly higher than the low- and medium-iodine groups (P < .01). The prevalence of hypothyroidism in the medium-iodine group was 0.2% (95% CI: 0.1%-0.4%), and was lower than the prevalence of the other 2 groups (P < .01). There was no difference in prevalence of hyperthyroidism in each group.
Thyroid nodules are the most easily detectable thyroid disease. These have a lower prevalence in the high-iodine group. The prevalence of most thyroid diseases is lowest for a UIC ranging from 100 to 299 μg/L. This serves as a reference for health policy-making with respect to iodine levels. Further studies on this topic should be carried out according to sufficient thyroid cancer data.
历史上,低碘摄入一直是中国的一个问题,导致碘缺乏病(IDD)广泛流行。中国于1995年开始推行全民食盐加碘,但甲状腺疾病增多的报告令人担忧,必须考虑适当的碘摄入量。
评估中国大陆普通人群中不同尿碘浓度(UIC)下甲状腺疾病的患病率。此外,我们旨在分析甲状腺疾病与UIC之间的关系,为制定关于碘摄入的有效健康政策提供指导。
检索PubMed、Cochrane、Embase、中国知网、万方和维普数据库,查找2016年1月前在中国内地发表的、基于社区的、有关UIC的随机相关研究。两名独立评审员从符合条件的文献中提取数据,获取不同UIC下甲状腺疾病的患病率以及组间交互P值。
纳入43篇文章。低碘组甲状腺结节患病率为22.3%(95%置信区间[CI]:20.6%-24.1%),中碘组为25.4%(95%CI:20.8%-28.8%),高碘组为6.8%(95%CI:2.8%-11.5%)。高碘组甲状腺结节患病率低于其他组。高碘组亚临床甲状腺功能减退患病率为8.3%(95%CI:3.8%-17.3%),显著高于低碘组和中碘组(P<0.01)。中碘组甲状腺功能减退患病率为0.2%(95%CI:0.1%-0.4%),低于其他两组患病率(P<0.01)。各组甲状腺功能亢进患病率无差异。
甲状腺结节是最易检出的甲状腺疾病。高碘组患病率较低。大多数甲状腺疾病患病率在UIC为100至299μg/L时最低。这可为碘水平相关的健康政策制定提供参考。应根据充足的甲状腺癌数据对该主题进行进一步研究。